DIMENSIONAL FUND ADVISORS LP

Position in MNKD — Mannkind Corp

CIK 354204 AUSTIN, TX

Position in MNKD

as of Mar 31, 2026 · filed May 7, 2026 Compact

Position Value

$12,135,571

-$13,059,656 QoQ

Shares Held

4,953,295

+11.5% QoQ

Ownership

1.60%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2024

8 quarters on record

Voting authority Sole 90.73519747965749.ToString("F0")% Shared 4.18678879412593.ToString("F0")% None 5.0780137262165885.ToString("F0")%

Healthcare · as of Mar 31, 2026

DIMENSIONAL FUND ADVISORS LP holds $5,003,215,874 across 223 Biotechnology names. MNKD ranks #66 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	989,342	$441,780,774
2	REGN	Regeneron Pharmaceuticals, Inc.	513,060	$396,410,676
3	JAZZ	Jazz Pharmaceuticals plc	1,895,215	$358,290,394
4	BMRN	Biomarin Pharmaceutical Inc	3,802,930	$214,827,514
5	ROIV	Roivant Sciences Ltd.	7,475,866	$207,081,486
6	INCY	Incyte Corp	1,975,544	$185,938,199
7	EXEL	Exelixis, Inc.	4,299,597	$184,409,714
8	HALO	Halozyme Therapeutics, Inc.	2,079,827	$134,419,216

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$12,135,571	4,953,295	+11.5%	Shares	Sole	2026-05-07
2025-12-31	$25,195,227	4,443,603	+10.6%	Shares	Sole	2026-02-12
2025-09-30	$21,569,580	4,016,682	-0.9%	Shares	Sole	2025-11-12
2025-06-30	$15,162,033	4,054,020	+15.0%	Shares	Sole	2025-08-12
2025-03-31	$17,732,534	3,525,355	+19.2%	Shares	Sole	2025-05-13
2024-12-31	$19,021,347	2,958,219	+40.7%	Shares	Sole	2025-02-13
2024-09-30	$13,227,602	2,102,958	+620.2%	Shares	Sole	2024-11-07
2024-06-30	$1,524,219	291,996	—	Shares	Sole	2024-08-09
No filing history on record for this holder in this stock.